CellRapeutics™ Leukopak from Type 2 Diabetes Donor (XS-0426-XU266)

Name: CellRapeutics™ Leukopak from Type 2 Diabetes Donor
SKU: XS-0426-XU266
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Harvested from donors with Type 2 Diabetes (T2DM), this Leukopak captures the systemic immune environment of "metainflammation." The leucocyte population reflects the impact of chronic hyperglycemia and hyperinsulinemia, often exhibiting a polarized proinflammatory monocyte compartment and altered T-cell metabolic profiles. This product is prioritized for research into the intersection of immunometabolism and the systemic vascular complications associated with insulin resistance.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Type 2 Diabetes Donor

Cat. No.
XS-0426-XU266

Donor Age
Middle-Aged, Senior

Donor Health
Diagnosed with T2DM. Leukocytes exhibit signatures of metabolic exhaustion and chronic inflammatory priming, reflecting the systemic impact of insulin resistance and prolonged glycemic stress.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Heparin or Acid Citrate Dextrose, formulated to counteract the effects of hyperglycemia on cell membrane fragility and metabolic exhaustion.

Additional Donor Information
Each lot features a Leukopak from donors with T2DM. Profiles include HbA1c levels, BMI, and metabolic syndrome markers, supporting research into chronic metabolic inflammation.

Clinical Profile
Disease duration, average HbA1c levels, Body Mass Index, and current management.

Additional Information

Medication History
Available upon request. Records of oral hypoglycemic agents, GLP-1 agonists, SGLT2 inhibitors, and management of metabolic comorbidities.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Type 2 Diabetes Donor, Leukopak, Type 2 Diabetes

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Type 2 Diabetes Donor (XS-0426-XU266). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.